RecruitingNCT06010199
Risk Stratification Value of Biomarkers in Patients With Myocarditis
Risk Stratification Value of Biomarkers in Patients With Myocarditis (FORWARD): a National, Multicenter, Retrospective-prospective, Cohort Study
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment
1,000 participants
Start Date
Aug 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Eligibility
Min Age: 3 YearsMax Age: 80 Years
Inclusion Criteria2
- All patients should meet the diagnostic criteria for myocarditis
- Patients who are regularly followed up at the corresponding cardiovascular center
Exclusion Criteria4
- Age <3 years or >80 years
- Pregnant or lactating women
- The patient refused to sign the informed consent and refused to participate in the study
- None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06010199
Related Trials
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT0615869810 locations
The Heart Hive - Cardiomyopathy Study
NCT046122961 location
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
NCT050460021 location
The Application of T1 Mapping in Real-World
NCT073546461 location
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
NCT044441281 location